Bide Pharmatech has been growing earnings at an average annual rate of 4.4%, while the Pharmaceuticals industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 10.8% per year. Bide Pharmatech's return on equity is 8%, and it has net margins of 12.4%.
Key information
4.42%
Earnings growth rate
-1.10%
EPS growth rate
Pharmaceuticals Industry Growth
10.90%
Revenue growth rate
10.84%
Return on equity
7.99%
Net Margin
12.43%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bide Pharmatech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
XSSC:688073 Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,351
168
302
59
31 Dec 25
1,324
152
298
59
30 Sep 25
1,270
153
280
56
30 Jun 25
1,197
139
274
53
31 Mar 25
1,136
122
257
55
31 Dec 24
1,102
117
247
56
30 Sep 24
1,098
80
269
64
30 Jun 24
1,101
78
267
63
31 Mar 24
1,102
99
261
59
31 Dec 23
1,092
110
254
60
30 Sep 23
1,050
161
217
52
30 Jun 23
988
171
196
51
31 Mar 23
909
157
182
50
31 Dec 22
834
146
171
43
30 Sep 22
768
129
165
39
30 Jun 22
707
114
165
34
31 Mar 22
649
101
155
34
31 Dec 21
606
98
148
32
31 Dec 20
391
59
108
18
31 Dec 19
249
-1
111
22
31 Dec 18
163
-19
90
13
Quality Earnings: 688073 has high quality earnings.
Growing Profit Margin: 688073's current net profit margins (12.4%) are higher than last year (10.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688073's earnings have grown by 4.4% per year over the past 5 years.
Accelerating Growth: 688073's earnings growth over the past year (37.6%) exceeds its 5-year average (4.4% per year).
Earnings vs Industry: 688073 earnings growth over the past year (37.6%) exceeded the Pharmaceuticals industry -1.6%.
Return on Equity
High ROE: 688073's Return on Equity (8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/11 18:12
End of Day Share Price
2026/06/11 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bide Pharmatech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.